-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GY7gqoAGrd3mgJqUvGUU7BDD7KyamltYLHdBJ96N5MAA+gmMfKnBj7xhrudH339a
 BevqYWX5vxDzT0k/bbrY3w==

<SEC-DOCUMENT>0001309014-09-000559.txt : 20090717
<SEC-HEADER>0001309014-09-000559.hdr.sgml : 20090717
<ACCEPTANCE-DATETIME>20090717060358
ACCESSION NUMBER:		0001309014-09-000559
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20090717
FILED AS OF DATE:		20090717
DATE AS OF CHANGE:		20090717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS ELECTRONICS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05146-01
		FILM NUMBER:		09949273

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>htm_4118.htm
<DESCRIPTION>LIVE FILING
<TEXT>
<!-- HTML Header Page -->
<HTML>
<HEAD>
<TITLE>
Koninklijke Philips Electronics N.V.&nbsp;-&nbsp;Form&nbsp;6-K
</TITLE>
</HEAD>
<!-- End HTML Header Page --><!-- Cover Page Header -->
<BODY bgcolor=white text=black>
<HR NOSHADE>
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P align="center">
<FONT size="+1"><B>
UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B>
</P>

<P>
<CENTER>
<FONT SIZE="+2" FACE="Arial"><B>Form 6-K</B></FONT><BR>

</CENTER>
</P>

<P>
<CENTER>
<FONT size="+1">
REPORT OF FOREIGN PRIVATE ISSUER<BR>PURSUANT TO RULE 13a-16 OR 15d-16<BR>UNDER THE SECURITIES EXCHANGE ACT OF 1934
</FONT>
</CENTER>
</P>
<P>
<CENTER>
July 17, 2009
</CENTER>
</P>
<P>
<CENTER>

</CENTER>
</P>
<!-- End Cover Page Header -->
<!-- Cover Page Registrant -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	<FONT SIZE="+2"><B>Koninklijke Philips Electronics N.V.</B></FONT><BR>
	<FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="CENTER" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	<FONT SIZE="-1">(Translation of registrant&#146;s name into English)</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	&nbsp;
    </TD>
  </TR>
<TR><TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5"><FONT FACE="Courier" SIZE="+0">The Netherlands</FONT><BR><FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT></TD></TR><TR><TD VALIGN="CENTER" ALIGN="CENTER" WIDTH="100%" COLSPAN="5"><FONT SIZE="-1">(Jurisdiction of incorporation or organization)</FONT></TD></TR><TR><TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">&nbsp;</TD></TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
      <FONT FACE="Courier" SIZE="+0">Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
        <FONT SIZE="-7">&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;</FONT><BR>
	    <FONT SIZE="-1">(Address of principal executive office)</FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="CENTER" WIDTH="100%" COLSPAN="5">
	&nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Cover Page Registrant -->
<!-- Checkboxes Page -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%" COLSPAN="5">
	Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:&nbsp;&nbsp;[<FONT FACE="Courier">x</FONT>]&nbsp;Form 20-F&nbsp;&nbsp;&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]&nbsp;Form 40-F
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:&nbsp;&nbsp;[<FONT FACE="Courier">&nbsp;</FONT>]&nbsp;Yes&nbsp;&nbsp;&nbsp;&nbsp;[<FONT FACE="Courier">x</FONT>]&nbsp;No
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" COLSPAN="5" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>
</TABLE>

<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
        If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):&nbsp;&nbsp;&nbsp;<FONT FACE="Courier"><U>&nbsp;n/a&nbsp;</U></FONT>
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
        &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Checkboxes Page -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- Report Page -->
<FONT SIZE="3">
<PRE>
This report comprises a copy of the following press releases:

- - &#8220;Philips expands emergency healthcare offering with acquisition of InnerCool
Therapies; a leader in body temperature management&#8221;, dated July 15, 2009;
- - &#8220;Philips strengthens position in lighting controls with acquisition of
US-based Teletrol Systems&#8221;, dated July 16, 2009.
</PRE>
</FONT>
<!-- End Report Page -->
<!-- Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
 <!-- Page Break  -->
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End Page Break -->
<!-- Signatures Page Header -->
<FONT SIZE="+1">
<CENTER>
<B>SIGNATURES</B>
</CENTER>
</FONT>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       &nbsp;
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="100%">
       &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Signatures Page Header -->
<!-- Signatures Page Details -->
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       Koninklijke Philips Electronics N.V.
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       &nbsp;
    </TD>
  </TR>

  <TR>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="40%">
       Date: July 17, 2009
    </TD>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="4%%">
       By:
    </TD>
    <TD VALIGN="TOP" ALIGN="LEFT" WIDTH="56%">
       /s/ E.P. Coutinho<BR><HR WIDTH="30%" NOSHADE>
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       Name:&nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
        E.P. Coutinho
    </TD>
  </TR>

  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       Title:
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       General Secretary
    </TD>
  </TR>
  <TR>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="40%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="4%%">
       &nbsp;
    </TD>
    <TD VALIGN="BOTTOM" ALIGN="LEFT" WIDTH="56%">
       &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End Signatures Page Details -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- Exhibit Index Header Page -->
<CENTER>
<FONT SIZE="+1"><B>
EXHIBIT&nbsp;INDEX
</B></FONT>
</CENTER>
<BR>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
  <TR VALIGN="BOTTOM">
    <TD NOWRAP ALIGN="LEFT" WIDTH="8%">
      <FONT SIZE="-1"><B>Exhibit No.</B></FONT>
    </TD>
    <TD WIDTH="15%">
      &nbsp;
    </TD>
    <TD NOWRAP ALIGN="LEFT" WIDTH="77%">
      <FONT SIZE="-1"><B>Description</B></FONT>
    </TD>
  </TR>
  <TR VALIGN="BOTTOM">
    <TD NOWRAP ALIGN="CENTER" WIDTH="8%">
      <HR SIZE="1" NOSHADE>
    </TD>
    <TD WIDTH="15%">
      &nbsp;
    </TD>
    <TD NOWRAP ALIGN="CENTER" WIDTH="77%">
      <HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
    </TD>
  </TR>
<!-- Exhibit Index Header Page -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.01<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- Exhibit Index Item -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      <FONT SIZE="-1">99.02<FONT>
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      <FONT SIZE="2">Press release</FONT>
    </TD>
  </TR>
<!-- End Exhibit Index Item -->
<!-- ExhibitIndexFooter -->
  <TR VALIGN="BOTTOM">
    <TD VALIGN="TOP" WIDTH="8%" nowrap>
      &nbsp;
    </TD>
    <TD WIDTH="15%">
       &nbsp;
    </TD>
    <TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
      &nbsp;
    </TD>
  </TR>
</TABLE>
<!-- End ExhibitIndexFooter -->
<!-- HR Page Break  -->
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<!-- End HR Page Break --><!-- HTML Footer Page -->
</BODY>
</HTML>
<!-- End HTML Footer Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.01
<SEQUENCE>2
<FILENAME>exhibit1.htm
<DESCRIPTION>EX-99.01
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.01
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips expands emergency healthcare offering with acquisition of InnerCool Therapies; a
leader in body temperature management
</FONT>

<P align="left" style="font-size: 12pt">Wednesday, July&nbsp;15, 2009


<P align="left" style="font-size: 12pt">Amsterdam, the Netherlands and San Diego, USA &#150; Royal Philips (AEX: PHI, NYSE: PHG) announced today
that it has reached an agreement to acquire the assets of InnerCool Therapies Inc., a pioneer in
the field of therapeutic hypothermia, which involves the management of a patient&#146;s body
temperature. InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM),
will be acquired in an asset purchase transaction for US $11.25&nbsp;million, as well as the transfer of
approximately US $1.5&nbsp;million&nbsp;in trade payables. The transaction will reinforce Philips&#146; leadership
position in the emergency care market by adding body temperature management solutions to its
existing product offering in this field.


<P align="left" style="font-size: 12pt">&#147;This acquisition is another example of our continuous strategy to focus on a patient&#146;s cycle of
care.&#148; said Steve Rusckowski, chief executive officer of Philips Healthcare. &#147;With InnerCool,
Philips is acquiring a true innovator in the field of temperature management. This will allow us to
broaden our offering in emergency care now, and also enable us to provide leadership in promising
future applications such as acute myocardial infarction and stroke, which could further preserve
heart and brain tissue.&#148;


<P align="left" style="font-size: 12pt">Therapeutic hypothermia solutions aim to safely induce, maintain and reverse hypothermia or
maintain normal body temperature, to preserve organs such as the heart and brain in the event of
Sudden Cardiac Arrest (SCA). This rapidly-advancing technology has been recognized by the American
Heart Association and the International Liaison Committee on Resuscitation as crucial in improving
the survival and neurological recovery for SCA patients.


<P align="left" style="font-size: 12pt">InnerCool Therapies will position Philips for continued growth in the cardiology care cycle by
enhancing its industry-leading emergency care solutions offered globally. Today this includes
comprehensive patient monitoring, clinical decision support tools, defibrillation therapy, CPR
measurement and feedback and medical consumables. Philips expects to see continued growth in
emergency care as medical systems and hospitals invest in innovative technologies which can
significantly impact the outcome for patients who experience life-threatening emergencies.


<P align="left" style="font-size: 12pt">With this acquisition, Philips becomes the only company that offers a comprehensive suite of both
surface (external)&nbsp;and endovascular (internal)&nbsp;body temperature management solutions in a market
currently experiencing double digit growth. More than 10&nbsp;years of extensive research and
development by InnerCool will also provide Philips with a rich patent portfolio and pipeline of
future products. Headquartered in San Diego, California, InnerCool Therapies was founded in 1998
and will be integrated into Philips&#146; Clinical Care Systems business.


<P align="left" style="font-size: 12pt">For further information, please contact:
<BR>
David Wolf
<BR>
Philips Electronics North America
<BR>
Tel: &#043; 1 212 536 0817
<BR>
Email: <U>david.l.wolf@philips.com</U>


<P align="left" style="font-size: 12pt">Steve Kelly
<BR>
Philips Healthcare Communications USA
<BR>
Tel: &#043;1 425 487 7479
<BR>
Email: <U>steve.kelly@philips.com</U>


<P align="left" style="font-size: 12pt">Joon Knapen
<BR>
Philips Corporate Communications
<BR>
Tel: &#043;31 20 59 77477
<BR>
Email: <U>joon.knapen@philips.com</U>


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and
Well-being company, focused on improving people&#146;s lives through timely innovations. As a world
leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into
people-centric solutions, based on fundamental customer insights and the brand promise of &#147;sense
and simplicity&#148;. Headquartered in the Netherlands, Philips employs approximately 116,000 employees
in more than 60 countries worldwide. With sales of EUR 26&nbsp;billion in 2008, the company is a market
leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new
lighting applications, as well as lifestyle products for personal well-being and pleasure with
strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral
healthcare. News from Philips is located at <U>www.philips.com/newscenter</U>.


<P align="left" style="font-size: 12pt">About InnerCool Therapies
<BR>
InnerCool Therapies was founded in San Diego, California in 1998 and develops and markets
temperature management systems for both surface and endovascular temperature control. Their systems
rapidly and controllably lower patient body temperature, and precisely maintain a specified target
temperature for the desired duration before returning the patient to normothermic levels.
InnerCool&#146;s endovascular solution utilizes a specialized catheter, with a highly responsive,
integrated temperature probe, eliminating the need for slow-to-react bladder or rectal probes.
InnerCool operates an approximately 17,000 square foot, FDA-registered and ISO-certified
manufacturing facility located in San Diego, California. For additional information about InnerCool
Therapies, please visit <U>www.innercool.com</U>.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.02
<SEQUENCE>3
<FILENAME>exhibit2.htm
<DESCRIPTION>EX-99.02
<TEXT>
<!-- ExhibitContentHeader Page -->
<HTML>
<HEAD>
<TITLE>
Exhibit&nbsp;&nbsp;EX-99.02
</TITLE>
</HEAD>
<!-- End HTML Header Page -->
<!-- ExhibitContentPage -->

<BODY style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt"><FONT style="font-size: 12pt">Philips strengthens position in lighting controls with acquisition of US-based Teletrol
Systems
</FONT>

<P align="left" style="font-size: 12pt">Thursday, July&nbsp;16, 2009


<P align="left" style="font-size: 12pt">Philips adds to portfolio of intelligent light and energy management solutions


<P align="left" style="font-size: 12pt">Amsterdam, the Netherlands and Manchester, NH, USA <B>&#150; </B>Royal Philips Electronics (AEX: PHI, NYSE:
PHG) announced today that it has acquired Teletrol Systems Inc., a leading supplier of integrated
solutions for simultaneous multi-site management of lighting and energy usage. The Teletrol product
portfolio will strengthen Philips&#146; range of sophisticated control solutions for institutional
customers, including the seamless, networked management of lighting and environment facilities,
including heating and air conditioning. Financial details of this agreement were not disclosed.


<P align="left" style="font-size: 12pt">&#147;Professional customers, such as retail chains, hotel groups and building owners with multiple
premises, increasingly demand better control over their lighting and energy use,&#148; said Rudy
Provoost, Chief Executive Officer of Philips Lighting. &#147;They also want to provide comfortable
environments for their employees, guests and residents, while at the same time keeping operational
and energy costs to a minimum. This acquisition will add significantly to the solutions we offer
those customers to meet these needs.&#148;


<P align="left" style="font-size: 12pt">Founded in 1985, Teletrol, based in Manchester, New Hampshire in the United States, has built up a
leading position in software and hardware-based energy management systems and controls, with
installations in more than 10,000 commercial and retail sites around the world. The company employs
37 employees, and has posted double-digit sales growth in recent years, a performance level which
is expected to continue in years to come as it leverages Philips&#146; existing global distribution
channels.


<P align="left" style="font-size: 12pt">Teletrol&#146;s operations will be incorporated into the Lighting Electronics group of the Philips
Lighting sector. The addition of Teletrol builds upon a program of strategic acquisitions by
Philips to expand the range of complete solutions it can offer across the lighting value chain.
Earlier this year Philips acquired the Australian lighting controls company Dynalite, while growing
its capabilities in architectural and entertainment lighting solutions with the acquisitions of
Ilti Luce in Italy, and Selecon of New Zealand.


<P align="left" style="font-size: 12pt">For further information, please contact:


<P align="left" style="font-size: 12pt">Joon Knapen
<BR>
Philips Corporate Communications
<BR>
Tel: &#043;31 20 59 77477
<BR>
Email: <U>joon.knapen@philips.com</U>


<P align="left" style="font-size: 12pt">David Wolf
<BR>
Philips Corporate Communications North America
<BR>
Tel: &#043;1 212 536 0817
<BR>
Email: <U>david.l.wolf@philips.com</U>


<P align="left" style="font-size: 12pt">About Royal Philips Electronics
<BR>
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and
Well-being company, focused on improving people&#146;s lives through timely innovations. As a world
leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into
people-centric solutions, based on fundamental customer insights and the brand promise of &#147;sense
and simplicity&#148;. Headquartered in the Netherlands, Philips employs approximately 116,000 employees
in more than 60 countries worldwide. With sales of EUR 26&nbsp;billion in 2008, the company is a market
leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new
lighting applications, as well as lifestyle products for personal well-being and pleasure with
strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral
healthcare. News from Philips is located at <U>www.philips.com/newscenter</U>.


<P align="left" style="font-size: 12pt">About Teletrol
<BR>
Teletrol is a leading supplier of IT-friendly energy management systems and building controls
designed around BACnet, Internet and Information Technology standards. Teletrol solutions enable
building owners to reduce energy consumption, improve occupant comfort and lower operating costs.
Teletrol&#146;s suite of software and hardware products enables building professionals to integrate,
automate, and manage buildings easily and efficiently&nbsp; Teletrol Systems Inc. is privately held by
Dean Kamen, entrepreneur, champion for science and technology, and inventor of the Segway HT,
located in Manchester, New Hampshire. For more information, please visit <U>www.teletrol.com</U>.


<P align="left" style="font-size: 12pt">Forward-looking statements
<BR>
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->
</BODY>

<!-- End ExhibitContentPage -->
<!-- ExhibitContentFooter Page -->
</HTML>
<!-- ExhibitContentFooter Page -->
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
